Biotech Archives - Page 730 of 733

2 minute read

Calithera Biosciences Announces First Patient Enrolled In Phase 2 Clinical Trial Of Sapanisertib In Relapsed/Refractory NRF2 (NFE2L2)-Mutated Squamous Non-Small Cell Lung Cancer

July 6, 4:01 PM

Calithera Biosciences, Inc. (NASDAQ:CALA), a clinical-stage, precision-oncology biopharmaceutical company, today announced that it has enrolled the first patient in a phase 2 clinical trial of sapanisertib (CB-228) in

CALA

1 minute read

Drugmakers, Health Authorities Discarding Several Million COVID-19 Vaccine Doses: Report

By Vandana Singh

July 6, 3:12 PM

Wall Street Journal reported that governments, drugmakers, and vaccination sites are discarding several unused COVID-19 vaccine doses amid declining…

AZN

1 minute read

Touchlight Inks Patent License Agreement With Pfizer

By Vandana Singh

July 6, 3:08 PM

Touchlight, a biotechnology company pioneering enzymatic DNA production, announced a non-exclusive patent license agreement with Pfizer Inc (NYSE:PFE). The pharma giant has…

PFE

1 minute read

AstraZeneca’s COVID-19 Treatment Allowed In China’s Southern City: Reuters

By Vandana Singh

July 6, 3:06 PM

AstraZeneca Plc’s (NASDAQ:AZN) COVID-19 antibody cocktail has been cleared for use in a medical tourism zone in China’s southern…

AZN

1 minute read

Erytech Pharma Granted Australia Patent Titled ‘Arginine Deiminase Encapsulated Inside Erythrocytes And Their Use In Treating Cancer’

By Bill Haddad

July 6, 2:08 PM

https://twitter.com/US_Patent_Plays/status/1544744441755353091

ERYP

1 minute read

NeuroMetrix Granted European Patent ‘Smart Electrode Assembly For Transcutaneous Electrical Nerve Stimulation’

By Bill Haddad

July 6, 1:51 PM

https://twitter.com/PatentGrants/status/1544740557804580864

NURO

1 minute read

This Analyst Believes Precigen’s Non-Healthcare Divesture Removes Financial Overhang

By Vandana Singh

July 6, 12:44 PM

Yesterday, Precigen Inc (NASDAQ: PGEN) agreed to sell its non-healthcare subsidiary to URUS.

PGEN

1 minute read

Sarepta Reports One Heart Inflammation Case In Duchenne Gene Therapy Trial

By Vandana Singh

July 6, 9:55 AM

Sarepta Therapeutics Inc (NASDAQ:SRPT) shared new functional data across multiple studies from the SRP-9001 (delandistrogene moxeparvovec) program for Duchenne muscular dystrophy. …

RHHBF

1 minute read

Immunome’s COVID-19 Cocktail Retains Neutralizing Activity Against Omicron Subvariants

By Vandana Singh

July 6, 9:28 AM

Immunome Inc (NASDAQ:IMNM) has announced that its cocktail (IMM-BCP-01) retained activity against the BA.4/5 and BA.2.12.1 subvariants in lab testing. IMM-BCP-01…

IMNM

3 minute read

The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer’s Drug Due In January, FDA Reviews Roche’s Lymphoma Candidate, Rare Pediatric Tag For Kazia’s Pediatric Brain Cancer Candidate

By Vandana Singh

July 6, 9:14 AM

Here's a roundup of top developments in the biotech space over the last 24 hours:

AMTI